latest news releases from the newsroom
Saab acquire 21% in Grintek
LINKOPING, Sweden, Jan. 15, 2004 (PRIMEZONE) -- Saab and Grintek have today increased their cooperation, whereby Saab acquire just over 21% in Grintek. The Grintek shareholders' have approved the deal.
Anna Klingspor proposed new board member in Hufvudstaden
STOCKHOLM, Sweden, Jan. 15, 2004 (PRIMEZONE) -- Shareholders representing more than 50 per cent of the shares and the votes in Hufvudstaden AB (publ) have informed the company that they intend to propose that the Annual General Meeting elect the following board members.
Notice of Extraordinary General Meeting
STOCKHOLM, Sweden, Jan. 15, 2004 (PRIMEZONE) -- Shareholders of Fastighets AB Tornet (publ) are hereby notified that an Extraordinary General Meeting will take place at 9.30 am on Friday, 30 January 2004 at Ingenjorshuset CityKonFerensen, Polhemssalen, Malmskillnadsgatan 46, Stockholm.
Crucell Signs PER.C6(TM) License Agreement with Biogen Idec
LEIDEN, The Netherlands, Jan. 15, 2004 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has signed a non-exclusive PER.C6(TM) technology research and commercialization license agreement with Biogen Idec, Inc. for the production of recombinant proteins to be used in in-house antibody discovery programs. Biogen Idec is one of the top three biotechnology companies in the United States. Under the terms of the agreement, Crucell will receive upfront and annual payments, as well as royalties on net sales of products discovered using the PER.C6(TM) technology in Biogen Idec's in-house discovery program. Further financial details were not disclosed.